Lung Foundation Australia announces new CEO

August 8 2018

Lung Foundation Australia, the peak body working to improve lung health and reduce the impact of lung disease in Australia, has today announced the appointment of Mr Mark Brooke as the new Chief Executive Officer.

Mark Brooke is a trusted, respected leader with over 27 years of executive experience leading a diverse range of not for profit organisations, including HeartKids, Asthma Australia and Playgroup Queensland. He is well known for his focus on leading consumer-centric and sustainable charities that are closely connected to the communities they serve.

Chair of Lung Foundation Australia, Professor Christine Jenkins, said she and the Board were delighted to welcome Mark as CEO.

“We were heartened by the high calibre of applicants for the role, but Mark was the outstanding candidate. He is a proven leader with the skills, experience and energy to lead Lung Foundation Australia into the future,” Professor Jenkins said.

“Having served as CEO for Asthma Australia from 2010-2016, Mark is well acquainted with many aspects of advocacy for people with lung disease and has forged strong relationships with many of our stakeholders and professional colleagues.

“We are delighted to have someone of Mark’s calibre take the reins at a time when the Foundation is working through a number of exciting opportunities that can be built upon and take us to new heights,” she said.

Mr Mark Brooke said he was both honoured and excited by the appointment.

“Over the years, Lung Foundation Australia has continued to strengthen its impact as an evidenced-based and outcomes focussed charity dedicated to improving the lives of people affected by lung disease,” Mr Brooke said.

“I look forward to working with the Board, the staff and stakeholders to build on past successes and embrace exiting new opportunities that will enable us to increase the scope and reach of our services so that even more people can benefit from our work,” he said.

The appointment follows the resignation of former CEO, Heather Allan, earlier this year.

“Heather played a critical role in the growth and success of the organisation. She leaves Lung Foundation Australia in a very strong position for future growth and we sincerely thank her for her contribution and leadership,” Professor Jenkins said.

“The Board has no doubt that Mark will lead the organisation very successfully to achieve our goals of further growth in community awareness, funding and policy support. I look forward to further success for Lung Foundation Australia under his leadership,” she said.